Is AdaptHealth Corp. (AHCO) Overvalued?
We dive into why AdaptHealth Corp. (AHCO) could be considered overvalued on 2026-08-07, based on AAII’s Value Score and Grade.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Michael Rose
Michael Rose
Jenna Brashear
Michael Rose
| Share Statistics | AHCO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $719.1 | $1,982.5 | 41% |
|
| Shares Out (Mil) | 136.1 | 77.7 | 69% |
|
| Institutional Ownership | 90.8% | 86.1% | 59% |
|
| Float (Mil) | 85.8 | 52.1 | 58% |
|
| Beta | 1.46 | 0.75 | 82% |
|
| Avg Daily Volume (000s) | 3,861 | 637 | 90% |
|
| Price Change (52-week) |
(42.8%) | 79.7% | 17% |
|
| Growth | AHCO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 24.8% | 10.9% | 86% |
|
| Net Income (5yr) | 15.2% | (1.6%) | 64% |
|
| EPS (5yr) | 29.8% | 0.3% | 81 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.6%) | (17.9%) | 48% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 5 | 5 | |
| Current EPS | ($0.064) | ($0.454) | ($0.128) | |
| Month Ago EPS | $0.340 | $0.892 | $1.166 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.319 | $0.841 | $1.174 | |
| Year/Year Chg | (94.0%) | (13.4%) | (101.0%) | |
| Financials | AHCO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,363 | $1,504 | 68% |
|
| Net Income (TTM) (Mil) | ($228) | $28 | 6% |
|
| EPS (TTM) | ($1.678) | $0.200 | 16% |
|
| Operating Cash Flow (TTM) (Mil) | $583 | $162 | 73% |
|
| Net Cash Flow (TTM) (Mil) | ($25) | $9 | 24% |
|
| Long-Term Debt (Q1) (Mil) | $2,002 | $338 | 74% |
|
| Enterprise Value (Q1) (Mil) | $2,789 | $2,416 | 53% |
|
| Valuation | AHCO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.52 | 2.79 | 8% |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | AHCO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 19.2% | 27.8% | 20% |
|
| Net Margin | (6.8%) | 1.2% | 24% |
|
| ROA | (5.3%) | 2.2% | 30% |
|
| ROE | (15.4%) | 7.2% | 25% |
|
| Liabilities to Assets | 68.1% | 58.6% | 64% |
|
| F-Score | 4 | 5 | 34% |
|
AdaptHealth Corp. did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors